Tandem Diabetes Care, Movi SpA Announce Agreement for Distribution of Insulin Pump Products

Tandem Diabetes Care Inc., a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, has entered into a distribution agreement with Movi SpA to commercialize Tandem’s t:slim X2 Insulin Pump in Italy.
 
“Partnering with experienced insulin pump distributors is key to our international commercialization strategy as we work to expand available insulin pump options for patients and healthcare providers worldwide,” said Kim Blickenstaff, president and CEO of Tandem Diabetes Care. “Movi shares in our passion to help improve the lives of people with diabetes, and we look forward to working with them to bring the t:slim X2 Insulin Pump to the diabetes communities in Italy.”

To learn more about Tandem Diabetes’ insulin pumps, watch the video below:



Under the terms of the arrangement Movi will perform all sales, marketing and customer training and support for Tandem’s products. Timing for availability of Tandem products in Italy has not yet been announced.
 
“We are proud to offer the t:slim X2 Insulin Pump to people with type 1 diabetes and healthcare providers in Italy, to provide an innovative and reliable alternative to the current market option,” said Enrico Piero Bassani, president of Movi. “We thank Tandem Diabetes Care for trusting us as their distributor for Italy, and we look forward to bringing the benefits of Tandem’s products to the patients and clinics that we service.”
 
Tandem Diabetes Care Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem manufactures and sells the t:slim X2 Insulin Pump, the only pump capable of remote feature updates using a personal computer and the only available pump with Dexcom G5® Mobile CGM integration. Tandem is based in San Diego, Calif.
 
Tandem Diabetes Care and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care Inc. in the United States and/or other countries. Dexcom and Dexcom G5 are registered trademarks of Dexcom Inc.